Search scope:
排序: Display mode:
Zinc homeostasis in the metabolic syndrome and diabetes
Xiao Miao, Weixia Sun, Yaowen Fu, Lining Miao, Lu Cai
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 31-52 doi: 10.1007/s11684-013-0251-9
Keywords: zinc zinc transporters metallothionein diabetes diabetic complications insulin resistance antioxidant
Baihui Xu, Jie Zhang, Yu Xu, Jieli Lu, Min Xu, Yuhong Chen, Yufang Bi, Guang Ning
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 132-137 doi: 10.1007/s11684-013-0250-x
Keywords: induced abortion spontaneous abortion metabolic syndrome
Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia
Meng Dong, Jun Lin, Wonchung Lim, Wanzhu Jin, Hyuek Jong Lee
Frontiers of Medicine 2018, Volume 12, Issue 2, Pages 130-138 doi: 10.1007/s11684-017-0555-2
Keywords: brown adipose tissue beige adipocyte anti-obesity anti-diabetes cancer cachexia aging
Association of metabolic syndrome with arterial compliance in children and adolescents
ZHANG Li, MI Jie, LI Ming, JIANG Benyu
Frontiers of Medicine 2007, Volume 1, Issue 1, Pages 68-73 doi: 10.1007/s11684-007-0014-6
Keywords: compliance assessment correlation analysis cardiovascular clustering HOMA-IR
Heng Fang, Aihua Zhang, Xiaohang Zhou, Jingbo Yu, Qi Song, Xijun Wang
Frontiers of Medicine 2020, Volume 14, Issue 5, Pages 651-663 doi: 10.1007/s11684-019-0709-5
Keywords: metabolomics liquid chromatography-mass spectrometry metabolites metabolic pathways
Zi-Jiang CHEN, Yuhua SHI
Frontiers of Medicine 2010, Volume 4, Issue 3, Pages 280-284 doi: 10.1007/s11684-010-0098-2
Keywords: polycystic ovary syndrome genetics metabolic disturbance
Clemens Drenowatz, Joseph J. Carlson, Karin A. Pfeiffer, Joey C. Eisenmann
Frontiers of Medicine 2012, Volume 6, Issue 4, Pages 428-435 doi: 10.1007/s11684-012-0232-4
The increasing prevalence of childhood overweight and obesity has been associated with an increased risk for cardiovascular disease (CVD). While several studies examined the effect of single behaviors such as physical activity (PA), sedentary behavior or diet on CVD risk, there is a lack of research on combined associations, specifically in children. Therefore, the purpose of this study was to examine the joint association of PA or screen time (ST) and diet on CVD risk factors in children. PA, ST and diet were assessed via questionnaire in 210 fifth grade students (age: 10.6±0.4 years). The healthy eating index (HEI) was subsequently calculated as indicator for diet quality. Height, weight, % body fat, and resting blood pressure were measured according to standard procedures and blood samples obtained via fingerprick were assayed for blood lipids. Total cholesterol HDL ratio (TC:HDL), mean arterial pressure (MAP), and % body fat were used as indicators of CVD risk. 55% of children did not meet current PA recommendations on at least 5 days/week and 70% exceeded current recommendations for ST. Further, only 2.5% possessed a “good” diet (HEI>80). There was no significant association of PA or ST and diet on CVD risk score. Neither TC:HDL, MAP, and % body fat nor the total CVD risk score was significantly correlated with diet, PA, or ST. Children in the high PA group, however, had significantly better diet scores. Despite the fact that self-reported PA, ST, or dietary intake were not directly related to CVD risk in this sample, higher activity levels were associated with a healthier diet and lower ST indicating an overall healthier lifestyle of this subgroup.
Keywords: exercise sedentary behavior metabolic syndrome health behavior adolescents TV time healthy eating index
Frontiers of Environmental Science & Engineering 2022, Volume 16, Issue 8, doi: 10.1007/s11783-022-1527-6
• The promoting effects for VFA generation follow the order of APG>SDBS>HTAB.
Keywords: Waste activated sludge (WAS) Volatile fatty acids (VFA) Surfactant types Functional microorganisms Metabolic
Atypical manifestations of acute coronary syndrome — throat discomfort: a multi-center observational
Frontiers of Medicine 2022, Volume 16, Issue 4, Pages 651-658 doi: 10.1007/s11684-021-0859-0
Keywords: acute coronary syndrome (ACS) throat discomfort (TD) throat pain cardiology departments non-cardiologic
Frontiers of Medicine 2021, Volume 15, Issue 5, Pages 679-692 doi: 10.1007/s11684-021-0866-1
Keywords: metabolic reprogramming potential of electron transfer cell proliferation aerobic glycolysis cancer
Metabolic hypertension: concept and practice
Zhiming Zhu, Peijian Wang, Shuangtao Ma
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 201-206 doi: 10.1007/s11684-013-0264-4
Keywords: hypertension cardiometabolic risk factors metabolic abnormalities
Jianping Ye
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 139-145 doi: 10.1007/s11684-015-0377-z
In obesity, chronic inflammation is believed to induce insulin resistance and impairs adipose tissue function. Although this view is supported by a large body of literature, it has been challenged by growing evidence that pro-inflammatory cytokines may favor insulin sensitivity through induction of energy expenditure. In this review article, interleukin 15 (IL-15) is used as a new example to explain the beneficial effects of the pro-inflammatory cytokines. IL-15 is secreted by multiple types of cells including macrophages, neutrophils and skeletal muscle cells. IL-15 expression is induced in immune cells by endotoxin and in muscle cells by physical exercise. Its transcription is induced by transcription factor NF-κB. IL-15 binds to its receptor that contains three different subunits (α, β and γ) to activate JAK/STAT, PI3K/Akt, IKK/NF-κB and JNK/AP1 pathways in cells. In the regulation of metabolism, IL-15 reduces weight gain without inhibiting food intake in rodents. IL-15 suppresses lipogenesis, stimulates brown fat function, improves insulin sensitivity through weight loss and energy expenditure. In human, circulating IL-15 is negatively associated with body weight. In the immune system, IL-15 stimulates proliferation and differentiation of T cells, NK cells, monocytes and neutrophils. In the anti-obesity effects of IL-15, T cells and NK cells are not required, but leptin receptor is required. In summary, evidence from human and rodents supports that the pro-inflammatory cytokine IL-15 may enhance energy expenditure to protect the body from obesity and type 2 diabetes. The mechanism of IL-15 action remains to be fully uncovered in the regulation of energy expenditure.
Keywords: inflammation obesity cytokine energy expenditure insulin resistance
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li, Jing Zhang, Weiping Jia
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 25-30 doi: 10.1007/s11684-013-0244-8
Keywords: FGF21 metabolism pharmacology physiology clinical relevance
Water-dispersible nano-pollutions reshape microbial metabolism in type-specific manners: A metabolic
Frontiers of Environmental Science & Engineering 2022, Volume 16, Issue 9, doi: 10.1007/s11783-022-1548-1
• Water-dispersible nano-pollutions exhibit type-specific toxic effects on E. coli.
Keywords: Nano-toxicity Nano-plastics Quantum dots Microbial metabolite Metabolic dysregulation
Metformin and metabolic diseases: a focus on hepatic aspects
Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 173-186 doi: 10.1007/s11684-015-0384-0
Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of type 2 diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses hepatic glucose production (HGP), serving as the main mechanism by which metformin improves hyperglycemia of T2D. Biochemically, metformin suppresses gluconeogenesis and stimulates glycolysis. Metformin also inhibits glycogenolysis, which is a pathway that critically contributes to elevated HGP. While generating beneficial effects on hyperglycemia, metformin also improves insulin resistance and corrects dyslipidemia in patients with T2D. These beneficial effects of metformin implicate a role for metformin in managing non-alcoholic fatty liver disease. As supported by the results from both human and animal studies, metformin improves hepatic steatosis and suppresses liver inflammation. Mechanistically, the beneficial effects of metformin on hepatic aspects are mediated through both adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. In addition, metformin is generally safe and may also benefit patients with other chronic liver diseases.
Keywords: metformin diabetes hepatic steatosis inflammatory response insulin resistance
Title Author Date Type Operation
Zinc homeostasis in the metabolic syndrome and diabetes
Xiao Miao, Weixia Sun, Yaowen Fu, Lining Miao, Lu Cai
Journal Article
Association between history of abortion and metabolic syndrome in middle-aged and elderly Chinese women
Baihui Xu, Jie Zhang, Yu Xu, Jieli Lu, Min Xu, Yuhong Chen, Yufang Bi, Guang Ning
Journal Article
Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia
Meng Dong, Jun Lin, Wonchung Lim, Wanzhu Jin, Hyuek Jong Lee
Journal Article
Association of metabolic syndrome with arterial compliance in children and adolescents
ZHANG Li, MI Jie, LI Ming, JIANG Benyu
Journal Article
High-throughput metabolomics reveals the perturbed metabolic pathways and biomarkers of Yang Huang syndrome
Heng Fang, Aihua Zhang, Xiaohang Zhou, Jingbo Yu, Qi Song, Xijun Wang
Journal Article
Joint association of physical activity/screen time and diet on CVD risk factors in 10-year-old children
Clemens Drenowatz, Joseph J. Carlson, Karin A. Pfeiffer, Joey C. Eisenmann
Journal Article
New insights into different surfactants’ impacts on sludge fermentation: Focusing on the particular metabolic
Journal Article
Atypical manifestations of acute coronary syndrome — throat discomfort: a multi-center observational
Journal Article
electron transfer and its application in dictating routes of biochemical processes associated with metabolic
Journal Article
Metabolic hypertension: concept and practice
Zhiming Zhu, Peijian Wang, Shuangtao Ma
Journal Article
Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes
Jianping Ye
Journal Article
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li, Jing Zhang, Weiping Jia
Journal Article
Water-dispersible nano-pollutions reshape microbial metabolism in type-specific manners: A metabolic
Journal Article